Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunogenicity of a third dose with mRNA-vaccines in the ChAdOx1-S/BNT162b2 vaccination regimen against SARS-CoV-2 variants.
García-Pérez J, Borobia AM, Pérez-Olmeda M, Portolés A, Castaño L, Campins-Artí M, Bertrán MJ, Bermejo M, Arribas JR, López A, Ascaso-Del-Rio A, Arana-Arri E, Fuentes Camps I, Vilella A, Cascajero A, García-Morales MT, Castillo de la Osa M, Pérez Ingidua C, Lora D, Jiménez-Santana P, Pino-Rosa S, Gómez de la Cámara A, De La Torre-Tarazona E, Calonge E, Cruces R, Belda-Iniesta C, Alcamí J, Frías J, Carcas AJ, Díez-Fuertes F; CombiVacS Study Group. García-Pérez J, et al. Among authors: diez fuertes f. iScience. 2024 Aug 14;27(9):110728. doi: 10.1016/j.isci.2024.110728. eCollection 2024 Sep 20. iScience. 2024. PMID: 39286494 Free PMC article.
Metagenomic sequencing, molecular characterization, and Bayesian phylogenetics of imported type 2 vaccine-derived poliovirus, Spain, 2021.
Fernandez-Garcia MD, Faye M, Diez-Fuertes F, Moreno-Docón A, Chirlaque-López MD, Faye O, Cabrerizo M. Fernandez-Garcia MD, et al. Among authors: diez fuertes f. Front Cell Infect Microbiol. 2023 May 2;13:1168355. doi: 10.3389/fcimb.2023.1168355. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37201115 Free PMC article.
Longer intervals between SARS-CoV-2 infection and mRNA-1273 doses improve the neutralization of different variants of concern.
García-Pérez J, Bermejo M, Ramírez-García A, De La Torre-Tarazona HE, Cascajero A, Castillo de la Osa M, Jiménez P, Aparicio Gómez M, Calonge E, Sancho-López A, Payares-Herrera C, Layunta Acero R, Vicente-Izquierdo L, Avendaño-Solá C, Alcamí J, Pérez-Olmeda M, Díez-Fuertes F. García-Pérez J, et al. Among authors: diez fuertes f. J Med Virol. 2023 Mar;95(3):e28679. doi: 10.1002/jmv.28679. J Med Virol. 2023. PMID: 36929737
Genetic Study of SARS-CoV-2 Non Structural Protein 12 in COVID-19 Patients Non Responders to Remdesivir.
Santos Bravo M, Alonso R, Soria D, Sánchez Palomino S, Sanzo Machuca Á, Rodríguez C, Alcamí J, Díez-Fuertes F, Simarro Redon À, Hurtado JC, Fernández Avilés F, Bodro M, Rubio E, Villanueva JL, Vergara A, Castro P, Tuset M, Cuesta G, Puerta P, García C, Mosquera Gutiérrez MDM, Martínez MJ, Vila J, Soriano A, Marcos MÁ. Santos Bravo M, et al. Among authors: diez fuertes f. Microbiol Spectr. 2022 Dec 21;10(6):e0244822. doi: 10.1128/spectrum.02448-22. Epub 2022 Nov 10. Microbiol Spectr. 2022. PMID: 36354320 Free PMC article.
Immune response and reactogenicity after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard mRNA vaccine (BNT162b2): RescueVacs multicenter cohort study.
Ascaso-Del-Rio A, García-Pérez J, Pérez-Olmeda M, Arana-Arri E, Vergara I, Pérez-Ingidua C, Bermejo M, Castillo de la Osa M, Imaz-Ayo N, Riaño Fernández I, Astasio González O, Díez-Fuertes F, Meijide S, Arrizabalaga J, Hernández Gutiérrez L, de la Torre-Tarazona HE, Mariano Lázaro A, Vargas-Castrillón E, Alcamí J, Portolés A; RescueVac study Group. Ascaso-Del-Rio A, et al. Among authors: diez fuertes f. EClinicalMedicine. 2022 Jul 1;51:101542. doi: 10.1016/j.eclinm.2022.101542. eCollection 2022 Sep. EClinicalMedicine. 2022. PMID: 35795398 Free PMC article.
Transcriptomic Evidence of the Immune Response Activation in Individuals With Limb Girdle Muscular Dystrophy Dominant 2 (LGMDD2) Contributes to Resistance to HIV-1 Infection.
Diez-Fuertes F, López-Huertas MR, García-Pérez J, Calonge E, Bermejo M, Mateos E, Martí P, Muelas N, Vílchez JJ, Coiras M, Alcamí J, Rodríguez-Mora S. Diez-Fuertes F, et al. Front Cell Dev Biol. 2022 May 13;10:839813. doi: 10.3389/fcell.2022.839813. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35646913 Free PMC article.
Increase of Diversity of Mumps Virus Genotype G SH Variants Circulating Among a Highly Immunized Population: Spain, 2007-2019.
Gavilán AM, Díez-Fuertes F, Sanz JC, Castellanos AM, López-Perea N, Jiménez SM, Ruiz-Sopeña C, Masa-Calles J, García-Comas L, de Ory F, Pérez-Olmeda M, Fernández-García A, Echevarría JE. Gavilán AM, et al. Among authors: diez fuertes f. J Infect Dis. 2022 Dec 28;227(1):151-160. doi: 10.1093/infdis/jiac176. J Infect Dis. 2022. PMID: 35524966
39 results